Expressive Writing Therapy for Breast Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how expressive writing can improve the health of Chinese immigrant women who have survived stage 0-III breast cancer. Participants will engage in writing sessions focusing on factual details about their cancer, stress and coping strategies, or positive reflections on their experience. The goal is to determine how writing might impact their well-being and recovery journey. Suitable candidates for this trial are women who completed their main cancer treatments in the last five years and have lived in the U.S. for at least six months. As an unphased study, this trial offers a unique opportunity to explore innovative ways to enhance recovery and well-being.
Do I need to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on expressive writing therapy for breast cancer survivors.
What prior data suggests that this expressive writing intervention is safe for breast cancer survivors?
Research has shown that expressive writing is generally safe and well-tolerated by cancer patients. One study found it improved both mental and physical health without causing harm. Another study found that breast cancer survivors who tried expressive writing did not report any major negative effects. Overall, this approach is considered low-risk and involves writing about personal experiences, feelings, and ways to manage stress. This suggests that expressive writing is a safe option for those looking to improve their well-being during cancer recovery.12345
Why are researchers excited about this trial?
Researchers are excited about the expressive writing therapies for breast cancer survivors because they offer a novel, non-medical approach to emotional healing. Unlike standard treatments, which often focus on physical recovery, these writing interventions aim to support mental and emotional well-being. The self-regulation writing encourages patients to explore stress and emotional coping, potentially enhancing psychological resilience. The self-cultivation writing focuses on fostering positive thoughts, which might improve quality of life by shifting patients' perspectives on their experiences. These interventions are simple, cost-effective, and can be self-administered, making them accessible options for long-term emotional support.
What evidence suggests that this trial's treatments could be effective for breast cancer survivors?
Research has shown that expressive writing therapy can improve both mental and physical well-being in cancer patients. In this trial, participants will engage in different writing interventions. Arm I involves control writing, where patients write about facts regarding their cancer diagnosis and treatment. Arm II focuses on self-regulation writing, emphasizing stress and coping, emotional disclosure, and benefit finding. Arm III involves self-cultivation writing, where patients express positive thoughts and feelings about their breast cancer experience. Previous studies have indicated that breast cancer patients who engaged in expressive writing felt less stressed and experienced better emotional health. Another study found that it improved the quality of life for breast cancer survivors. However, not all studies agree, and some found no major benefits. Overall, expressive writing might help some people by providing an outlet to share their thoughts and feelings about their cancer journey.13467
Who Is on the Research Team?
Qian Lu, MD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for foreign-born Chinese women, aged 18 or older, who have been living in the U.S. for at least six months and were diagnosed with stage 0-III breast cancer. Participants should have completed primary treatments like surgery or chemotherapy within the last five years.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in expressive writing sessions, writing about their cancer experiences for 3 weekly 30-minute sessions
Follow-up
Participants are monitored for quality of life and stress biomarkers at 6 weeks, 6 months, and 12 months
What Are the Treatments Tested in This Trial?
Interventions
- Culturally Based Brief Expressive Writing Intervention
Culturally Based Brief Expressive Writing Intervention is already approved in United States for the following indications:
- Improvement of health in Chinese immigrant stage 0-III breast cancer survivors
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator